Showing 941 - 960 results of 20,793 for search '"therapy"', query time: 0.08s Refine Results
  1. 941
  2. 942

    Successful Treatment of Acromegaly and Associated Hypogonadism with First-Line Clomiphene Therapy by Juan D. Palacios, Ricardo J. Komotar, Atil Y. Kargi

    Published 2018-01-01
    “…Clomiphene citrate (CC) has been reported as an effective add-on therapy to somatostatin analogs and dopamine agonists in patients with acromegaly accompanied by hypogonadism; its use as a single agent to treat acromegaly and associated hypogonadism following incomplete surgery has not been previously reported. …”
    Get full text
    Article
  3. 943
  4. 944

    Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease by Qiyue Wang, Shuyi Mi, Zixuan Yu, Qiyi Li, Jiacai Lei

    Published 2020-01-01
    “…Moreover, comparing the latest data, this review also presented potential future prospect for adjuvant therapies.…”
    Get full text
    Article
  5. 945
  6. 946
  7. 947

    Rescue of Mutant CFTR Channel Activity by Investigational Co-Potentiator Therapy by Mafalda Bacalhau, Filipa C. Ferreira, Marcelo Folhadella M. F. Azevedo, Talita P. Rosa, Camilla D. Buarque, Miquéias Lopes-Pacheco

    Published 2025-01-01
    “…The additive rescue of p.Arg334Trp-, p.Ser549Arg-, p.Gly551Asp-, and p.Ser945Leu-CFTR also indicates that these variants could benefit from the development of a co-potentiator therapy.…”
    Get full text
    Article
  8. 948
  9. 949

    Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments by Teba Alnima, Peter W. de Leeuw, Abraham A. Kroon

    Published 2012-01-01
    “…In the past few years, novel accomplishments have been obtained in carotid baroreflex activation therapy (BAT) for the treatment of resistant hypertension. …”
    Get full text
    Article
  10. 950

    A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies by Hanyin Wang, Hande Tuncer

    Published 2018-01-01
    “…The value of combination therapy for refractory ITP is not well defined. We present the case of a 29-year-old male with severe ITP refractory to initial standard therapy including steroids, IVIG, and subsequent splenectomy, who was treated with the combination therapy of rituximab, romiplostim, and mycophenolate and eventually developed thrombocytosis requiring plateletpheresis. …”
    Get full text
    Article
  11. 951

    Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician’s Choices by Asim Jamal Shaikh, Shiyam Kumar, Sajjad Raza, Maria Mehboob, Osama Ishtiaq

    Published 2012-01-01
    “…The choice of adjuvant hormonal therapy in postmenopausal women with hormone receptor positive breast cancer has remained a matter of controversy and debate. …”
    Get full text
    Article
  12. 952
  13. 953

    Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research by Baixin Ye, Qingping Gao, Zhi Zeng, Creed M. Stary, Zhihong Jian, Xiaoxing Xiong, Lijuan Gu

    Published 2016-01-01
    “…A lack of cellular homogeneity contributes to difficulty in designing targeted oncological therapies. Therefore, the development of novel methods to determine and characterize oncologic cellular heterogeneity is a critical next step in the development of novel cancer therapies. …”
    Get full text
    Article
  14. 954

    Empathy enhancement through group play therapy to reduce aggressive behavior by Iswinarti Iswinarti, Nurul Hidayah

    Published 2020-10-01
    “…The results showed that Group Play Therapy can enhance children's empathy so that it can reduce aggressive behavior.…”
    Get full text
    Article
  15. 955
  16. 956
  17. 957

    Rational Emotive Behavior Therapy (REBT) Guidelines To Reduce Student Aggressiveness by Dewi Aswira Putri, Frischa Meivilona Yendi, Taufik Taufik, Verlanda Yuca

    Published 2019-12-01
    Subjects: “…aggressive, group guidance, rational emotive behavior therapy (rebt).…”
    Get full text
    Article
  18. 958
  19. 959

    Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia by Philipp Koehler, Patrick Schmidt, Andreas A. Hombach, Michael Hallek, Hinrich Abken

    Published 2012-01-01
    “…In this paper we discuss the potential of the strategy in the treatment of CLL, the currently ongoing trials, and the future challenges in the adoptive therapy with CAR-engineered T cells.…”
    Get full text
    Article
  20. 960